PharmaCyte Biotech Inc.

NASDAQ: PMCB · Real-Time Price · USD
1.02
0.12 (13.35%)
At close: Aug 18, 2025, 3:59 PM
1.02
0.00%
After-hours: Aug 18, 2025, 07:48 PM EDT

PharmaCyte Biotech Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
Revenue
n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a
Operating Income
-4,377.9B -6.52M -6.46M -4.39M -3.62M
Interest Income
1.42M 3.4M 1.94M 157.65K 3.05
Pretax Income
23,362.1B 333.76K -4.32M -4.24M -3.55M
Net Income
30.66M 333.76K -4.32M -4.24M -3.55M
Selling & General & Admin
3.94M 6.11M 5.99M 3.7M 2.71M
Research & Development
438.42K 407.43K 468.54K 690.94K 916.25K
Other Expenses
n/a -8 -494 -14 -249
Operating Expenses
4.38M 6.52M 6.46M 4.39M 3.62M
Interest Expense
n/a n/a n/a 509.00 3.05K
Selling & Marketing Expenses
n/a 1.32M 1.23M 1.54M n/a
Cost & Expenses
4.38M 6.52M 6.46M 4.39M 3.62M
Income Tax Expense
n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
7.33M 9.58M 19.49M 15.52M 1.45M
Shares Outstanding (Diluted)
7.33M 9.58M 5.18M 5.18M 1.45M
EPS (Basic)
3.19 -1.8 -0.22 -0.27 -2.46
EPS (Diluted)
3.19 -1.8 -0.83 -0.79 -2.46
EBITDA
30.66M 333.76K -4.32M -4.24M -3.55M
EBIT
30.66M 333.76K -6.46M -4.24M -3.55M
Depreciation & Amortization
n/a 6.52M 6.46M n/a n/a